SEC Tracker
Get the app
XTNT · XBRL financial data

Xtant Medical Holdings financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (XTNT's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Revenue from contracts with customers25,01928,108*27,87329,94327,93731,513*32,90435,41133,25532,357*20,88423,031
Cost of goods and services sold9,68510,971*10,57111,36111,63015,489*12,66111,12711,26314,603*8,9139,701
Gross profit15,33417,137*17,30218,58216,30716,024*20,24324,28421,99217,754*11,97113,330
Research and development490492*527636701522*443566634459*435695
General and administrative7,1448,867*7,7857,7137,4935,700*7,5337,4787,0717,293*6,2736,436
Total operating expenses18,71920,943*20,77221,52820,08417,906*19,18019,66019,45118,698*14,89422,499
Operating income (loss)(3,385)(3,806)*(3,470)(2,946)(3,777)(1,882)*1,0634,6242,541(944)*(2,923)(9,169)
Interest income4816*———————year only2191
Interest expense760818*8359921,1991,134*1,0451,004904718*599542
Other income (expense)—year only12(5)(13)(27)*(9)7(16)91*242347
Income tax expense (benefit)(2,300)577*68366221*(25)2552571,541*2773
Net income (loss)9,231(4,303)*(4,400)(3,861)(5,024)(3,165)*583,5501,30857*(3,089)(9,413)
Earnings per share, basic USD per share0.07(0.03)*(0.03)(0.03)(0.04)(0.02)*0.000.030.010.00*(0.02)(0.07)
Earnings per share, diluted USD per share0.07(0.03)*(0.03)(0.03)(0.04)(0.02)*0.000.020.010.00*(0.02)(0.07)
Weighted average shares, basic thousands of shares128,140130,111*130,201130,270135,100139,015*139,069139,311139,713140,022*140,059140,259
Weighted average shares, diluted thousands of shares135,663153,136*130,201130,270135,100139,015*143,335148,574150,377157,722*140,059140,259

Balance sheet

CSV

Fiscal quarters (XTNT's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Cash and cash equivalents8,6645,7154,5475,3796,5966,1995,0326,92310,40017,05312,1379,870
Accounts receivable19,15020,73121,48421,18720,54520,66023,47626,95125,51717,80317,17919,416
Inventory34,33436,88538,72440,50741,88638,63438,81240,13540,71430,26331,88133,287
Prepaid and other current assets1,8741,3301,7091,8001,8931,6011,4211,4661,4582,3891,4041,857
Total current assets64,10764,86966,54168,97271,41067,11669,14475,58978,33078,24562,62164,777
Property and equipment, net9,0978,6928,8678,83710,28410,13110,72610,44710,0096,2025,8545,542
Right-of-use asset1,5941,5231,4371,1179958297362,6343,6193,1923,0452,894
Goodwill6,5147,3027,3027,3027,3027,3027,3027,3027,3026,0746,0746,074
Total assets92,00392,61293,93195,57898,88293,83795,833103,479106,32194,14578,00079,667
Accounts payable5,3587,0547,3786,8758,2987,9187,1217,2236,8563,8445,4856,154
Accrued liabilities8,93410,4199,8758,6768,8717,77110,49210,62611,53510,6268,4757,481
Current portion of long-term debt2,833———2,750————3,5003,7203,720
Total current liabilities21,92122,99028,44228,31133,66928,58129,58130,60035,50329,48418,77329,963
Long-term debt14,35217,16716,82621,77019,13822,03822,16722,27817,40411,0268,0957,287
Lease liability, non-current9167596443762471661212,0152,9492,6652,5252,397
Total liabilities37,32241,26346,25150,57353,15750,87451,95654,97755,93843,19229,40139,652
Accumulated deficit(238,707)(243,010)(247,410)(251,271)(256,295)(259,459)(259,401)(255,851)(254,543)(254,486)(257,575)(266,988)
Total stockholders' equity54,68151,34947,68045,00545,72542,96343,87748,50250,38350,95348,59940,015
Total liabilities and equity92,00392,61293,93195,57898,88293,83795,833103,479106,32194,14578,00079,667
Common shares outstanding (cover page) thousands of shares130,110130,217130,217130,314139,008139,068139,323130,316140,004140,068140,263140,288

Cash flows

CSV

Fiscal quarters (XTNT's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Net income (loss)9,231(4,303)*(4,400)(3,861)(5,024)(3,165)*583,5501,30857*(3,089)(9,413)
Stock-based compensation745*938*9101,2001,100840*758800600727*746875*
Depreciation and amortization883*1,017*1,005998*1,073*1,148*1,0741,169*1,161*1,819*534508*
Net cash from operating activities(3,834)*(915)*(5,755)(5,088)*(1,718)*665*1,2781,276*4,612*5,380*(2,114)(7,308)*
Purchases of property and equipment223*363*773564*2,104*672*1,191366*430*395*194247*
Net cash from investing activities(4,656)*(2,313)*(674)(480)*(2,009)*(567)*(1,143)(317)*4,679*4,680*10,220(5,191)*
Proceeds from issuing common stock—year only——————————
Proceeds from long-term debt0*(138)*——0*0*——————
Repayments of long-term debt—————————3,000*2,841930*
Net cash from financing activities12,844*325*5,1796,434*5,314*(854)*(919)662*(5,771)*(3,542)*(13,275)10,558*
Net change in cash4,301*(2,826)*(1,299)854*1,608*(865)*(786)1,602*3,604*6,687*(5,171)(1,940)*

Compare with peers

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
Xtant Medical Holdings9,87023,031(7,308)*140.3M1.4 quarters 10-QJun 30, 2026
Hyperfine43,4583,904(7,268)*not reported6.0 quarters 10-QJun 30, 2026
Vivani Medical19,894not reported(6,035)*90.2M3.3 quarters 10-QJun 30, 2026
Vivos2,33636(740)*494.2M3.2 quarters 10-QJun 30, 2026
Alpha Pro Tech18,901not reported2,213*10.2M— 10-QJun 30, 2026
Nuo Therapeutics449not reported(236)*48.4M1.9 quarters 10-QJun 30, 2026
Fractyl Health47,140not reported(15,901)*159.2M3.0 quarters 10-QJun 30, 2026
Milestone Scientific2,067not reported(585)*88.7M3.5 quarters 10-QJun 30, 2026
Vicarious Surgical1,407not reported(6,325)not reported0.6 quarters 10-QMar 31, 2026

Not investment advice. Not affiliated with the U.S. SEC.